Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Treos Bio
company
About
Treos Bio, Inc. develops precision cancer immunotherapies tailored to patients' genetics.
- London,England,United Kingdom
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $8M
- Industries
- Biotechnology,Clinical Trials,Health Care,Health Diagnostics,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Treos Bio, Inc. is a computational immunology and immunotherapy company which has developed a proprietary technology to predict in silico likely responders to cancer immunotherapies and to design in silico next generation targeted immunotherapies for a large population of cancer patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$8M €25.67M
Treos Bio has raised a total of
$8M €25.67M
in funding over 2 rounds. Their latest funding was raised on
Mar 31, 2021 from a Convertable Note round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 31, 2021 | Convertable Note | €14M | 2 |
Luminous Ventures
|
— | Detail |
| Mar 20, 2021 | Series A | €11.67M | 1 | — | — | Detail |
| Feb 13, 2017 | Series Unknown | $8M | 1 |
BXR Partners LLP
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
4
Treos Bio is funded by 4 investors.
Luminous Ventures
and The Future Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Luminous Ventures
|
Yes | Convertable Note |
|
|
Yes | Convertable Note |
|
BXR Partners LLP
|
Yes | Series Unknown |
Outsized Ventures
|
— | Series A |
Employee Profiles
Number of Employee Profiles
5
Treos Bio has 5 current employee profiles, including
Executive John Hautman
Executive
Executive
Executive
Employee
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
